These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Current state of lung transplantation]. Schilling W Z Erkr Atmungsorgane; 1990; 175(3):111-9. PubMed ID: 2080629 [TBL] [Abstract][Full Text] [Related]
30. Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome? Madill J; Aghdassi E; Arendt B; Hartman-Craven B; Gutierrez C; Chow CW; Allard J; Transplant Rev (Orlando); 2009 Apr; 23(2):103-10. PubMed ID: 19298941 [TBL] [Abstract][Full Text] [Related]
31. Audit of referral and explant diagnoses in lung transplantation: a pathologic study of lungs removed for parenchymal disease. Stewart S; McNeil K; Nashef SA; Wells FC; Higenbottam TW; Wallwork J J Heart Lung Transplant; 1995; 14(6 Pt 1):1173-86. PubMed ID: 8719465 [TBL] [Abstract][Full Text] [Related]
32. [Lung and heart-lung transplantation in respiratory tract diseases. Evaluation and development of the indications based on our first 15 cases]. Couraud L; Baudet E; Martigne C; Roques X; Velly JF; Laborde N; Clerc P Ann Chir; 1989; 43(8):602-7. PubMed ID: 2589794 [TBL] [Abstract][Full Text] [Related]
33. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Yousem SA; Paradis IL; Dauber JH; Zeevi A; Duquesnoy RJ; Dal Col R; Armitage J; Hardesty RL; Griffith BP Transplantation; 1989 Mar; 47(3):564-9. PubMed ID: 2493702 [No Abstract] [Full Text] [Related]
35. Long-term outcome of lung transplantation for cystic fibrosis--Danish results. Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981 [TBL] [Abstract][Full Text] [Related]
36. Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients. Dosanjh A Eur J Pharmacol; 2006 May; 536(3):219-22. PubMed ID: 16581063 [TBL] [Abstract][Full Text] [Related]
37. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation. Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297 [TBL] [Abstract][Full Text] [Related]